Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
uniQure N.V. | Director | Ordinary Shares | 22.5K | $108K | $4.81 | Jun 19, 2024 | Direct |
Corbus Pharmaceuticals Holdings, Inc. | Director | Common Stock, par value $0.0001 per share | 2.78K | $83.5K | $30.00 | May 30, 2024 | Direct |
Corbus Pharmaceuticals Holdings, Inc. | Director | Stock Option (right to buy) | 2.78K | $13.8K | $4.97 | May 16, 2024 | Direct |
Akari Therapeutics Plc | Chief Executive Officer, Director | Ordinary Shares, par value $0.0001 per share | 1.02B | Apr 26, 2024 | Direct | ||
uniQure N.V. | Director | Stock Option (Right to Buy) | 15.8K | Jun 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
QURE | uniQure N.V. | Jun 19, 2024 | 2 | $0 | 4 | Jun 21, 2024 | Director |
QURE | uniQure N.V. | Jun 13, 2024 | 1 | -$11.4K | 4 | Jun 17, 2024 | Director |
CRBP | Corbus Pharmaceuticals Holdings, Inc. | May 30, 2024 | 1 | $0 | 4 | Jun 3, 2024 | Director |
CRBP | Corbus Pharmaceuticals Holdings, Inc. | May 16, 2024 | 1 | $0 | 4 | May 20, 2024 | Director |
AKTX | Akari Therapeutics Plc | Apr 26, 2024 | 1 | $0 | 4 | Apr 30, 2024 | Chief Executive Officer, Director |
AKTX | Akari Therapeutics Plc | Jan 1, 2024 | 0 | $0 | 3 | Jan 2, 2024 | Chief Executive Officer, Director |
QURE | uniQure N.V. | Jun 13, 2023 | 3 | -$43.2K | 4 | Jun 20, 2023 | Director |
CRBP | Corbus Pharmaceuticals Holdings, Inc. | May 18, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
QURE | uniQure N.V. | Feb 27, 2023 | 1 | -$7.69K | 4 | Mar 1, 2023 | Director |
QURE | uniQure N.V. | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
CRBP | Corbus Pharmaceuticals Holdings, Inc. | May 18, 2022 | 1 | $0 | 4 | May 19, 2022 | Director |
QURE | uniQure N.V. | Feb 24, 2022 | 2 | $0 | 4 | Feb 28, 2022 | Director |
QURE | uniQure N.V. | Oct 21, 2021 | 1 | $0 | 4 | Oct 22, 2021 | Director |
QURE | uniQure N.V. | Oct 21, 2021 | 0 | $0 | 3 | Oct 22, 2021 | Director |
CRBP | Corbus Pharmaceuticals Holdings, Inc. | Jun 17, 2021 | 2 | $0 | 4 | Jun 17, 2021 | Director |